Related Experiment Video
Updated: Feb 24, 2026

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth
Published on: December 22, 2020
The molecular mechanism underlying unconventional secretion of Fibroblast Growth Factor 2 from tumour cells
Julia P Steringer1, Walter Nickel1
1Heidelberg University Biochemistry Center, Heidelberg, Germany.
Abstract:
Fibroblast Growth Factor 2 (FGF2) is a potent cell survival factor involved in tumour-induced angiogenesis. FGF2 is secreted from cells through an unconventional secretory mechanism based upon direct translocation across the plasma membrane. The molecular mechanism underlying this process depends on a surprisingly small set of trans-acting factors that are physically associated with the plasma membrane. FGF2 membrane translocation is mediated by the ability of FGF2 to oligomerise and to insert into the plasma membrane in a PI(4,5)P2 -dependent manner. Membrane-inserted FGF2 oligomers are dynamic translocation intermediates that are disassembled at the extracellular leaflet mediated by membrane proximal heparan sulphate proteoglycans. This process results in the exposure of FGF2 on cell surfaces as part of its unconventional mechanism of secretion. Although the trans-acting factors and cis-elements in FGF2 required for unconventional secretion have been known for a while, the core mechanism of this mysterious process has now been reconstituted with purified components establishing the molecular basis of FGF2 secretion from tumour cells.
Insights
Fibroblast Growth Factor 2 (FGF2) secretion from tumor cells involves direct plasma membrane translocation. This study reconstitutes the core mechanism using purified components, revealing FGF2
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Fibroblast Growth Factor 2 (FGF2) is a key cell survival factor promoting tumor angiogenesis.
- FGF2 utilizes an unconventional secretory pathway, translocating directly across the plasma membrane.
- The molecular machinery for FGF2 unconventional secretion involves specific trans-acting factors and cis-elements.
Purpose of the Study:
- To elucidate the molecular mechanism of FGF2 unconventional secretion.
- To reconstitute the FGF2 secretion process using purified components.
- To establish the molecular basis for FGF2 release from tumor cells.
Main Methods:
- Reconstitution of FGF2 membrane translocation using purified FGF2, lipids, and associated factors.
- Analysis of FGF2 oligomerization and PI(4,5)P2-dependent membrane insertion.
- Investigating the role of heparan sulfate proteoglycans in disassembling membrane-inserted FGF2 oligomers.
Main Results:
- FGF2 membrane translocation is dependent on its ability to oligomerize and insert into the plasma membrane in a PI(4,5)P2-dependent manner.
- Membrane-inserted FGF2 oligomers serve as dynamic translocation intermediates.
- Heparan sulfate proteoglycans mediate the disassembly of these intermediates at the extracellular leaflet, exposing FGF2.
Conclusions:
- The core molecular mechanism of FGF2 unconventional secretion has been reconstituted with purified components.
- This study establishes the fundamental molecular basis for FGF2 release from tumor cells.
- Understanding FGF2 secretion provides insights into tumor-induced angiogenesis and potential therapeutic targets.
More Related Videos
09:52A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication
Published on: September 20, 2016
15:43Experimental Generation of Carcinoma-Associated Fibroblasts CAFs from Human Mammary Fibroblasts
Published on: October 25, 2011
Related Concept Videos
Mitogens and the Cell Cycle
TGF - β Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The Tumor Microenvironment
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Regulation of Angiogenesis and Blood Supply